CVS Health Corporation (CVS) Given Media Impact Rating of 0.10
Media coverage about CVS Health Corporation (NYSE:CVS) has trended somewhat positive recently, Accern Sentiment reports. The research group identifies positive and negative press coverage by analyzing more than twenty million blog and news sources in real-time. Accern ranks coverage of public companies on a scale of negative one to positive one, with scores nearest to one being the most favorable. CVS Health Corporation earned a news impact score of 0.10 on Accern’s scale. Accern also assigned news articles about the pharmacy operator an impact score of 45.8411795898444 out of 100, meaning that recent press coverage is somewhat unlikely to have an impact on the company’s share price in the next few days.
These are some of the media headlines that may have effected Accern Sentiment’s analysis:
- Corporate America donates over $27 million to Harvey relief — so far (krdo.com)
- CVS Board Ignored Overbilling Scheme, Shareholder Suit Says (law360.com)
- CVS Health Corporation (CVS) Given Average Rating of “Buy” by Analysts (americanbankingnews.com)
- CVS Health and the CVS Health Foundation Donate $200,000 Towards – KAIT Jonesboro, AR – Region 8 News, weather, sports (kait8.com)
- CVS Health Corporation (CVS) Now Covered by Loop Capital (currenthollywood.com)
Shares of CVS Health Corporation (NYSE CVS) opened at 76.09 on Wednesday. The firm has a market capitalization of $77.35 billion, a P/E ratio of 15.16 and a beta of 0.91. CVS Health Corporation has a 52-week low of $69.30 and a 52-week high of $94.30. The stock’s 50 day moving average is $78.28 and its 200-day moving average is $78.95.
CVS Health Corporation (NYSE:CVS) last issued its quarterly earnings data on Tuesday, August 8th. The pharmacy operator reported $1.33 earnings per share (EPS) for the quarter, beating the Zacks’ consensus estimate of $1.31 by $0.02. The firm had revenue of $45.69 billion during the quarter, compared to analysts’ expectations of $45.36 billion. CVS Health Corporation had a net margin of 2.93% and a return on equity of 17.47%. The business’s revenue for the quarter was up 4.5% on a year-over-year basis. During the same quarter in the previous year, the company earned $1.32 earnings per share. On average, equities analysts forecast that CVS Health Corporation will post $5.88 earnings per share for the current fiscal year.
The company also recently disclosed a quarterly dividend, which was paid on Thursday, August 3rd. Investors of record on Monday, July 24th were issued a dividend of $0.50 per share. This represents a $2.00 dividend on an annualized basis and a yield of 2.63%. The ex-dividend date was Thursday, July 20th. CVS Health Corporation’s dividend payout ratio is currently 39.92%.
CVS has been the topic of a number of research reports. Evercore ISI reissued an “outperform” rating and set a $88.00 price target (up previously from $87.00) on shares of CVS Health Corporation in a report on Wednesday, May 3rd. Vetr raised CVS Health Corporation from a “buy” rating to a “strong-buy” rating and set a $85.96 price target on the stock in a report on Wednesday, May 17th. ValuEngine lowered CVS Health Corporation from a “buy” rating to a “hold” rating in a report on Friday, June 2nd. Jefferies Group LLC reissued a “hold” rating and set a $82.00 price target on shares of CVS Health Corporation in a report on Friday, June 9th. Finally, Cowen and Company reissued an “outperform” rating and set a $86.00 price target on shares of CVS Health Corporation in a report on Tuesday, June 13th. One research analyst has rated the stock with a sell rating, nine have given a hold rating and fourteen have assigned a buy rating to the company. The stock presently has an average rating of “Buy” and an average target price of $90.83.
ILLEGAL ACTIVITY WARNING: “CVS Health Corporation (CVS) Given Media Impact Rating of 0.10” was first posted by The Cerbat Gem and is the property of of The Cerbat Gem. If you are accessing this piece of content on another domain, it was illegally copied and republished in violation of United States and international trademark and copyright law. The correct version of this piece of content can be read at https://www.thecerbatgem.com/2017/08/30/cvs-health-corporation-cvs-given-media-impact-rating-of-0-10.html.
In related news, CFO David M. Denton sold 230,510 shares of the business’s stock in a transaction that occurred on Monday, June 12th. The shares were sold at an average price of $80.00, for a total transaction of $18,440,800.00. Following the completion of the transaction, the chief financial officer now owns 176,983 shares in the company, valued at $14,158,640. The sale was disclosed in a filing with the SEC, which can be accessed through the SEC website. Also, Director Richard J. Swift sold 2,500 shares of the business’s stock in a transaction that occurred on Wednesday, August 16th. The shares were sold at an average price of $79.62, for a total transaction of $199,050.00. Following the transaction, the director now owns 3,258 shares of the company’s stock, valued at approximately $259,401.96. The disclosure for this sale can be found here. In the last 90 days, insiders have sold 273,675 shares of company stock valued at $21,831,647. Corporate insiders own 0.61% of the company’s stock.
About CVS Health Corporation
CVS Health Corporation, together with its subsidiaries, is an integrated pharmacy healthcare company. The Company provides pharmacy care for the senior community through Omnicare, Inc (Omnicare) and Omnicare’s long-term care (LTC) operations, which include distribution of pharmaceuticals, related pharmacy consulting and other ancillary services to chronic care facilities and other care settings.
Receive News & Stock Ratings for CVS Health Corporation Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CVS Health Corporation and related stocks with our FREE daily email newsletter.